| 000 | 01340 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514024852.0 | ||
| 264 | 0 | _c20020423 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a1470-3203 | ||
| 024 | 7 |
_a10.3317/jraas.2001.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSwift, P A | |
| 245 | 0 | 0 |
_aRenoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers. _h[electronic resource] |
| 260 |
_bJournal of the renin-angiotensin-aldosterone system : JRAAS _cSep 2001 |
||
| 300 |
_a170-3 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Review | ||
| 650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIrbesartan |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aLosartan _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
| 700 | 1 | _aMacGregor, G A | |
| 773 | 0 |
_tJournal of the renin-angiotensin-aldosterone system : JRAAS _gvol. 2 _gno. 3 _gp. 170-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3317/jraas.2001.023 _zAvailable from publisher's website |
| 999 |
_c11787974 _d11787974 |
||